Status:
COMPLETED
A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Osteoarthritis
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the safety and effectiveness of an investigational drug and an approved drug in the treatment of osteoarthritis of the knee and hip.
Detailed Description
The duration of treatment is 26 weeks.
Eligibility Criteria
Inclusion
- Osteoarthritis of the knee or hip which requires treatment with a medication to obtain pain relief
Exclusion
- Any known allergy to the study drugs
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2005
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00092768
Start Date
March 1 2004
End Date
February 1 2005
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.